Peanut allergy impact on productivity and quality of life (PAPRIQUA): Caregiver-reported psychosocial impact of peanut allergy on children.
Adaptation, Psychological
Adolescent
Adolescent Behavior
Adult
Age Factors
Aged
Anxiety
/ diagnosis
Caregivers
/ psychology
Child
Child Behavior
Child, Preschool
Cost of Illness
Cross-Sectional Studies
Efficiency
Female
Health Surveys
Humans
Male
Middle Aged
Peanut Hypersensitivity
/ diagnosis
Quality of Life
Risk Factors
Severity of Illness Index
Sex Factors
United Kingdom
Young Adult
food allergy
paediatrics
quality of life
Journal
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
ISSN: 1365-2222
Titre abrégé: Clin Exp Allergy
Pays: England
ID NLM: 8906443
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
11
02
2020
revised:
28
07
2020
accepted:
08
08
2020
pubmed:
1
9
2020
medline:
3
11
2021
entrez:
1
9
2020
Statut:
ppublish
Résumé
Limited research has examined the impact of peanut allergy (PA) on children using validated instruments to assess psychosocial burden and the factors influencing burden. The PAPRIQUA study aimed to assess the caregiver-reported impact of living with PA on children's health-related quality of life (HRQL), correlations between PA severity and child's sex, and associations of caregivers' sex and anxiety with the proxy report of their child's HRQL and to identify significant predictors of a child's HRQL. A cross-sectional survey of caregivers of children with mild, moderate and severe PA, based on caregiver perception, was conducted in the United Kingdom. Participants were recruited through a survey recruitment panel; a maximum quota of 20% who rated their child's PA as mild was set to ensure population diversity; however, the quota was not required as few participants considered their child's PA mild. The survey, funded by Aimmune Therapeutics, included sociodemographic and clinical questions, the EQ-5D-Y, Hospital Anxiety and Depression Scale, Food Allergy Quality of Life Questionnaire-Parent Form (FAQLQ-PF) and Food Allergy Independent Measure (FAIM). One hundred caregivers of children with PA (aged 4-15 years) completed the survey. Child's sex was not associated with proxy-reported burden. For younger children (aged 4-10 years), there was no effect of PA severity; parents of older children (aged 11-15 years) reported low to higher burden for their child on the EQ-5D-Y and FAQLQ-PF dependent upon PA severity. For all measures of child burden except the EQ-5D-Y, two or more reactions in the past 12 months and parental anxiety significantly predicted higher levels of burden for the child (P < .05-P < .001). Experiencing a life-threatening event in the past 12 months significantly predicted EQ-5D-Y proxy utility (P < .01). Caregivers report that children with PA experience high levels of psychosocial burden, particularly those with more severe PA and a reaction history. Interventions to decrease caregiver anxiety and reaction frequency may help reduce the child's burden. Self-report studies in children with PA would help confirm these findings.
Sections du résumé
BACKGROUND
Limited research has examined the impact of peanut allergy (PA) on children using validated instruments to assess psychosocial burden and the factors influencing burden.
OBJECTIVE
The PAPRIQUA study aimed to assess the caregiver-reported impact of living with PA on children's health-related quality of life (HRQL), correlations between PA severity and child's sex, and associations of caregivers' sex and anxiety with the proxy report of their child's HRQL and to identify significant predictors of a child's HRQL.
METHODS
A cross-sectional survey of caregivers of children with mild, moderate and severe PA, based on caregiver perception, was conducted in the United Kingdom. Participants were recruited through a survey recruitment panel; a maximum quota of 20% who rated their child's PA as mild was set to ensure population diversity; however, the quota was not required as few participants considered their child's PA mild. The survey, funded by Aimmune Therapeutics, included sociodemographic and clinical questions, the EQ-5D-Y, Hospital Anxiety and Depression Scale, Food Allergy Quality of Life Questionnaire-Parent Form (FAQLQ-PF) and Food Allergy Independent Measure (FAIM).
RESULTS
One hundred caregivers of children with PA (aged 4-15 years) completed the survey. Child's sex was not associated with proxy-reported burden. For younger children (aged 4-10 years), there was no effect of PA severity; parents of older children (aged 11-15 years) reported low to higher burden for their child on the EQ-5D-Y and FAQLQ-PF dependent upon PA severity. For all measures of child burden except the EQ-5D-Y, two or more reactions in the past 12 months and parental anxiety significantly predicted higher levels of burden for the child (P < .05-P < .001). Experiencing a life-threatening event in the past 12 months significantly predicted EQ-5D-Y proxy utility (P < .01).
CONCLUSIONS AND CLINICAL RELEVANCE
Caregivers report that children with PA experience high levels of psychosocial burden, particularly those with more severe PA and a reaction history. Interventions to decrease caregiver anxiety and reaction frequency may help reduce the child's burden. Self-report studies in children with PA would help confirm these findings.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1249-1257Informations de copyright
© 2020 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd.
Références
Nwaru BI, Hickstein L, Panesar SS, et al. The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy. 2014;69(1):62-75.
Scott LA, Jones BI, Berni TR, Berni ER, De Vries J, Currie CJ. Evaluation of the epidemiology of peanut allergy in the United Kingdom. Expert Rev Clin Immunol. 2019;15(12):1333-1339.
Venter C, Hasan Arshad S, Grundy J, et al. Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UK. Allergy. 2010;65(1):103-108.
Sicherer SH, Sampson HA. Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol. 2007;120(3):491-503.
Joo Chan C, Richardo T, Lim RLH. Current trend in immunotherapy for peanut allergy. Int Rev Immunol. 2018;37(6):279-290.
Cook QS, Kim EH. Update on peanut allergy: prevention and immunotherapy. Allergy Asthma Proc. 2019;40(1):14-20.
Patel N, Herbert L, Green TD. The emotional, social, and financial burden of food allergies on children and their families. Allergy Asthma Proc. 2017;38(2):88-91.
Avery NJ, King RM, Knight S, Hourihane JOB. Assessment of quality of life in children with peanut allergy. Pediatr Allergy Immunol. 2003;14(5):378-382.
King RM, Knibb RC, Hourihane JOB. Impact of peanut allergy on quality of life, stress and anxiety in the family. Allergy. 2009;64(3):461-468.
Saleh-Langenberg J, Goossens NJ, Flokstra-de Blok BMJ, et al. Predictors of health-related quality of life of European food-allergic patients. Allergy. 2015;70(6):616-624.
Chow C, Pincus DB, Comer JS. Pediatric food allergies and psychosocial functioning: examining the potential moderating roles of maternal distress and overprotection. J Pediatr Psychol. 2015;40(10):1065-1074.
Thörnqvist V, Middelveld R, Wai HM, et al. Health-related quality of life worsens by school age amongst children with food allergy. Clinical Transl Allergy. 2019;9(1):10.
DunnGalvin A, Treneva M, Pampura A, Grebenko A, Makatsori M, Munblit D. Quality of life associated with maternal anxiety disorder in Russian children and adolescents with food allergy. Pediatr Allergy Immunol. 2020;31(1):78-84.
Stensgaard A, Bindslev-Jensen C, Nielsen D. Peanut allergy as a family project: social relations and transitions in adolescence. J Clin Nurs. 2017;26(21-22):3371-3381.
Stensgaard A, Bindslev-Jensen C, Nielsen D, Munch M, DunnGalvin A. Quality of life in childhood, adolescence and adult food allergy: patient and parent perspectives. Clin Exp Allergy. 2017;47(4):530-539.
Roy KM, Roberts MC. Peanut allergy in children: relationships to health-related quality of life, anxiety, and parental stress. Clin Pediatr. 2011;50(11):1045-1051.
Wille N, Badia X, Bonsel G, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Research. 2010;19(6):875-886.
Ravens-Sieberer U, Wille N, Badia X, et al. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010;19(6):887-897.
Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095-1108.
DunnGalvin A, De Blok BMJ, Dubois A, Hourihane JOB. Development and validation of the Food Allergy Quality of Life-Parent Administered Questionnaire (FAQLQ-PF) for food allergic children aged 0-12 years. Clin Exp Allergy. 2008;38:977-986.
Van der Velde JL, Flokstra-de Blok BM, DuinnGalvin A, Hourihane JO'B, Duiverman EJ, Dubois AEJ. Parents report better health-related quality of life for their food-allergic children than children themselves. Clin Exp Allergy. 2011;41(10):1431-1439.
Van der Velde JL, Dubois AE, Flokstra-de Blok BM. All items of the food allergy quality of life questionnaires are relevant for peanut-allergic patients. Allergy. 2019;74(4):831-834.
van der Velde JL, Flokstra-de Blok BMJ, Vlieg-Boerstra BJ, et al. Development, validity and reliability of the food allergy independent measure (FAIM). Allergy. 2010;65(5):630-635.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatry Scand. 1983;67:361-370.
Breeman S, Cotton S, Fielding S, Jones GT. Normative data for the hospital anxiety and depression scale. Qual Life Res. 2015;24(2):391-398.
Bjelland I, Dahl A, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52(2):69-77.
Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edn. New York, NY: Lawrence Erlbaum Associates; 1988.
Janssen B, Szende A. Population norms for the EQ-5D. In Self-Reported Population Health: An International Perspective Based on EQ-5D. DordrechtSpringer; 2014:19-30.
Protudjer JL, Jansson SA, Heibert Arnlind M, et al. Household costs associated with objectively diagnosed allergy to staple foods in children and adolescents. J Allergy Clin Immunol Pract. 2015;3(1):68-75.
Van der Velde JL, Flokstra-de Blok BM, Dunngalvin A, Hourihane JO, Duiverman EJ, Dubois AE. Parents report better health-related quality of life for their food-allergic children than children themselves. Clin Exper Allergy. 2011;41(10):1431-1439.